Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
International Forum of Allergy & Rhinology|March 4, 2022
The roles of eosinophils and interleukin-5 in the pathophysiology of chronic rhinosinusitis with nasal polypsPhilippe Gevaert, Joseph K Han, Steven G Smith, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 14, 2021
Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension StudyGerald J Gleich, Florence Roufosse, Geoffrey Chupp, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 21, 2017
Evaluation of Potential Continuation Rules for Mepolizumab Treatment of Severe Eosinophilic AsthmaNecdet B Gunsoy, Sarah M Cockle, Steven W Yancey, et al.
Respiratory Medicine|June 15, 2017
Evaluation of the psychometric properties of the St George's Respiratory Questionnaire in patients with severe asthmaLinda M Nelsen, Margaret Vernon, Hector Ortega, et al.
Respiratory Medicine|June 21, 2019
Effect of mepolizumab in severe eosinophilic asthma according to omalizumab eligibilityMarc Humbert, Frank C Albers, Daniel J Bratton, et al.
Advances in Therapy|June 28, 2018
Rapid and Consistent Improvements in Morning PEF in Patients with Severe Eosinophilic Asthma Treated with MepolizumabHector Ortega, Andrew Menzies-Gow, Jean-Pierre Llanos, et al.
The Korean Journal of Internal Medicine|May 26, 2020
Efficacy and safety of mepolizumab in Korean patients with severe eosinophilic asthma from the DREAM and MENSA studiesMi-Kyeong Kim, Hae-Sim Park, Choon-Sik Park, et al.
British Journal of Clinical Pharmacology|July 22, 2021
A Phase 1 study of the long-acting anti-IL-5 monoclonal antibody GSK3511294 in patients with asthmaDave Singh, Rainard Fuhr, Nicholas P Bird, et al.
Rheumatology International|February 4, 2020
Pharmacogenetic investigation of efficacy response to mepolizumab in eosinophilic granulomatosis with polyangiitisLynn D Condreay, Laura R Parham, Xiaoyan A Qu, et al.
Chest|October 21, 2005
Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma controlRobert A Nathan, Steven W Yancey, Kelli Waitkus-Edwards, et al.
Pageof 7